Muslim

The End of Disparate Impact: HHS Overhauls Title VI Civil Rights Enforcement

• Breast Cancer Legislation and Policy

The End of Disparate Impact: HHS Overhauls Title VI Civil Rights Enforcement

Muslim October 11, 2026

Introduction On July 23, 2026, the U.S. Department of Health and Human Services (HHS) finalized a sweeping...

Read More Read more about The End of Disparate Impact: HHS Overhauls Title VI Civil Rights Enforcement

Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves

• Treatment Innovations

Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves

Muslim October 10, 2026

The global biopharmaceutical landscape is undergoing a period of intense scrutiny and strategic recalibration. As regulatory agencies...

Read More Read more about Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves

The Intersection of GLP-1 Medications and Breast Cancer: Navigating Emerging Research

• Survivorship and Post-Treatment

The Intersection of GLP-1 Medications and Breast Cancer: Navigating Emerging Research

Muslim October 10, 2026

Written by Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information provided in this article is...

Read More Read more about The Intersection of GLP-1 Medications and Breast Cancer: Navigating Emerging Research

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

• Clinical Oncology Education

Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

Muslim October 9, 2026

The landscape of oncology is currently undergoing a paradigm shift, driven by a deeper understanding of molecular...

Read More Read more about Advancing the Frontier of Oncology: Taylor & Francis Calls for Submissions on Biliary Cancer Innovation

A Global Beacon of Hope: The #LightUpMBC Campaign Targets Metastatic Breast Cancer

• Metastatic Breast Cancer Research

A Global Beacon of Hope: The #LightUpMBC Campaign Targets Metastatic Breast Cancer

Muslim October 9, 2026

NEW YORK, NY – As October arrives, the cultural landscape is typically awash in pink ribbons, signaling...

Read More Read more about A Global Beacon of Hope: The #LightUpMBC Campaign Targets Metastatic Breast Cancer

Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

• Breast Cancer Surgery and Reconstruction

Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

Muslim October 9, 2026

For decades, the standard path for breast reconstruction following a mastectomy has been defined by two primary...

Read More Read more about Beyond Implants: The Rise of Autologous Fat Transfer in Post-Mastectomy Breast Reconstruction

Viatris Bolsters Pain Management Portfolio with Strategic Acquisition of Pacira Assets

• Chemotherapy and Targeted Therapy

Viatris Bolsters Pain Management Portfolio with Strategic Acquisition of Pacira Assets

Muslim October 9, 2026

By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...

Read More Read more about Viatris Bolsters Pain Management Portfolio with Strategic Acquisition of Pacira Assets

Bridging the Divide: New National Survey Highlights Urgent Need for Standardized Breast Cancer Care Across Canada

• Global Breast Cancer Awareness

Bridging the Divide: New National Survey Highlights Urgent Need for Standardized Breast Cancer Care Across Canada

Muslim October 9, 2026

A new national survey commissioned by Breast Cancer Canada has unveiled a startling consensus among Canadians: the...

Read More Read more about Bridging the Divide: New National Survey Highlights Urgent Need for Standardized Breast Cancer Care Across Canada

Breaking the Silence: Sonorous Neurovascular Secures FDA IDE Approval for Pulsatile Tinnitus Breakthrough

• Treatment Innovations

Breaking the Silence: Sonorous Neurovascular Secures FDA IDE Approval for Pulsatile Tinnitus Breakthrough

Muslim October 8, 2026

In a landmark development for neurovascular medicine, California-based Sonorous Neurovascular has secured Investigational Device Exemption (IDE) approval...

Read More Read more about Breaking the Silence: Sonorous Neurovascular Secures FDA IDE Approval for Pulsatile Tinnitus Breakthrough

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

• Chemotherapy and Targeted Therapy

The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery

Muslim October 8, 2026

In the rapidly evolving landscape of preclinical research, a paradigm shift is underway. For decades, the pathology...

Read More Read more about The Digital Renaissance: Transforming Archived Tissue into a Gateway for Ethical Drug Discovery